| John Morcos, | |
|
400 Oakbrook Dr, Suite 2201, Greensburg, PA 15601-6403 | |
| (724) 834-1463 | |
| Not Available |
| Full Name | John Morcos |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 23 Years |
| Location | 400 Oakbrook Dr, Greensburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013052216 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD424962 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Excela Health - Frick Hospital | Mount pleasant, PA | Hospital |
| Excela Health Westmoreland Regional Hospital | Greensburg, PA | Hospital |
| Excela Health Latrobe Hospital | Latrobe, PA | Hospital |
| Upmc Presbyterian Shadyside | Pittsburgh, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mountain View Cancer Associates | 5597666792 | 25 |
News Archive
An analysis of medical-record data from more than 17.5 million patients found that people with inflammatory bowel disease (IBD) are at elevated risk for a heart attack, regardless of whether or not they have traditional risk factors for heart disease such as high cholesterol, high blood pressure and smoking.
In a new study the secret for a longer life is uncovered. Not surprisingly it lies more in a healthy and happy lifestyle than in just genetics. Researchers say that being a Centenarian is increasingly more common these days.
Lombard Medical, Inc, a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAA), exhibited its Aorfix Endovascular stent graft system at the 18th international experts' symposium, Critical Issues in Aortic Endografting, in Malmö, Sweden on June 27-28, 2014.
Oxford Gene Technology (OGT), a provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has extended its Genefficiency™ Sequencing Service to provide a dedicated service for investigating rare diseases. The specifically optimised version of the service will help investigators and clinicians identify causative mutations quickly, easily and without the need for in-house technical or bioinformatics expertise.
High-dose interleukin-2 can be effective in selected metastatic renal cell cancer patients pre-treated with VEGF-targeted agents, reveals research presented today at the ESMO Symposium on Immuno-Oncology in Geneva, Switzerland.
› Verified 8 days ago
| Entity Name | Mountain View Cancer Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013984376 PECOS PAC ID: 5597666792 Enrollment ID: O20040120000532 |
News Archive
An analysis of medical-record data from more than 17.5 million patients found that people with inflammatory bowel disease (IBD) are at elevated risk for a heart attack, regardless of whether or not they have traditional risk factors for heart disease such as high cholesterol, high blood pressure and smoking.
In a new study the secret for a longer life is uncovered. Not surprisingly it lies more in a healthy and happy lifestyle than in just genetics. Researchers say that being a Centenarian is increasingly more common these days.
Lombard Medical, Inc, a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAA), exhibited its Aorfix Endovascular stent graft system at the 18th international experts' symposium, Critical Issues in Aortic Endografting, in Malmö, Sweden on June 27-28, 2014.
Oxford Gene Technology (OGT), a provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has extended its Genefficiency™ Sequencing Service to provide a dedicated service for investigating rare diseases. The specifically optimised version of the service will help investigators and clinicians identify causative mutations quickly, easily and without the need for in-house technical or bioinformatics expertise.
High-dose interleukin-2 can be effective in selected metastatic renal cell cancer patients pre-treated with VEGF-targeted agents, reveals research presented today at the ESMO Symposium on Immuno-Oncology in Geneva, Switzerland.
› Verified 8 days ago
| Entity Name | Hematology Oncology Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114994324 PECOS PAC ID: 2860413002 Enrollment ID: O20051215000107 |
News Archive
An analysis of medical-record data from more than 17.5 million patients found that people with inflammatory bowel disease (IBD) are at elevated risk for a heart attack, regardless of whether or not they have traditional risk factors for heart disease such as high cholesterol, high blood pressure and smoking.
In a new study the secret for a longer life is uncovered. Not surprisingly it lies more in a healthy and happy lifestyle than in just genetics. Researchers say that being a Centenarian is increasingly more common these days.
Lombard Medical, Inc, a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAA), exhibited its Aorfix Endovascular stent graft system at the 18th international experts' symposium, Critical Issues in Aortic Endografting, in Malmö, Sweden on June 27-28, 2014.
Oxford Gene Technology (OGT), a provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has extended its Genefficiency™ Sequencing Service to provide a dedicated service for investigating rare diseases. The specifically optimised version of the service will help investigators and clinicians identify causative mutations quickly, easily and without the need for in-house technical or bioinformatics expertise.
High-dose interleukin-2 can be effective in selected metastatic renal cell cancer patients pre-treated with VEGF-targeted agents, reveals research presented today at the ESMO Symposium on Immuno-Oncology in Geneva, Switzerland.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Morcos, 5150 Centre Ave, Room 456, Pittsburgh, PA 15232-1309 Ph: () - | John Morcos, 400 Oakbrook Dr, Suite 2201, Greensburg, PA 15601-6403 Ph: (724) 834-1463 |
News Archive
An analysis of medical-record data from more than 17.5 million patients found that people with inflammatory bowel disease (IBD) are at elevated risk for a heart attack, regardless of whether or not they have traditional risk factors for heart disease such as high cholesterol, high blood pressure and smoking.
In a new study the secret for a longer life is uncovered. Not surprisingly it lies more in a healthy and happy lifestyle than in just genetics. Researchers say that being a Centenarian is increasingly more common these days.
Lombard Medical, Inc, a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAA), exhibited its Aorfix Endovascular stent graft system at the 18th international experts' symposium, Critical Issues in Aortic Endografting, in Malmö, Sweden on June 27-28, 2014.
Oxford Gene Technology (OGT), a provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has extended its Genefficiency™ Sequencing Service to provide a dedicated service for investigating rare diseases. The specifically optimised version of the service will help investigators and clinicians identify causative mutations quickly, easily and without the need for in-house technical or bioinformatics expertise.
High-dose interleukin-2 can be effective in selected metastatic renal cell cancer patients pre-treated with VEGF-targeted agents, reveals research presented today at the ESMO Symposium on Immuno-Oncology in Geneva, Switzerland.
› Verified 8 days ago
Nawaf I Nseir, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 562 Shearer St Ste B104, Greensburg, PA 15601 Phone: 724-836-8303 Fax: 724-836-8311 | |
Thomas George Tomci, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 539 Green St, Greensburg, PA 15601 Phone: 724-834-1122 Fax: 724-838-8112 | |
James E Adisey, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 530 South St, Second Floor, Greensburg, PA 15601 Phone: 724-689-1358 Fax: 724-689-0547 | |
Robert Gordon Tymoczko, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 545 Rugh St., Greensburg, PA 15601 Phone: 724-836-8400 | |
Gautam Agrawal, M.D , M.P.H Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 562 Shearer St Ste B104, Greensburg, PA 15601 Phone: 724-836-8303 Fax: 724-836-8311 | |
Matthew G Sulecki, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 200 Village Dr, Greensburg, PA 15601 Phone: 724-838-1900 Fax: 724-838-5620 |